Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Wen-Ho Chang

Showing results (1-10 of 20) with videos related to

Pageof 2
Sort By:
Journal of Clinical Psychopharmacology|August 13, 2002
Fluvoxamine-clozapine interaction: time-dependent?Mong-Liang Lu, Hsien-Yuan Lane, Wen-Ho Chang
Journal of Clinical Psychopharmacology|November 28, 2002
Dosing strategies of clozapine-fluvoxamine cotreatmentMong-Liang Lu, Hsien-Yuan Lane, Michael W Jann, et al.
Pharmacogenomics|May 11, 2005
Pharmacogenetic studies of response to risperidone and other newer atypical antipsychoticsHsien-Yuan Lane, Cheng-Chun Lee, Yi-Ching Liu, et al.
The Journal of Clinical Psychiatry|August 5, 2004
Adjunctive fluvoxamine inhibits clozapine-related weight gain and metabolic disturbancesMong-Liang Lu, Hsien-Yuan Lane, Shih-Ku Lin, et al.
Journal of Clinical Psychopharmacology|July 14, 2005
Regular-dose risperidone on QTc intervalsChih-Chiang Chiu, Wen-Ho Chang, Ming-Chyi Huang, et al.
Journal of Clinical Psychopharmacology|August 13, 2002
Influences of patient-related variables on risperidone efficacy for acutely exacerbated schizophrenia: analyses with rigorous statisticsHsien-Yuan Lane, Yue-Cune Chang, Chi-Chiang Chiu, et al.
The American Journal of Psychiatry|August 31, 2002
Association of risperidone treatment response with a polymorphism in the 5-HT(2A) receptor geneHsien-Yuan Lane, Yue-Cune Chang, Chih-Chiang Chiu, et al.
The International Journal of Neuropsychopharmacology|May 14, 2004
Effects of dopamine D2 receptor Ser311Cys polymorphism and clinical factors on risperidone efficacy for positive and negative symptoms and social functionHsien-Yuan Lane, Cheng-Chun Lee, Yue-Cune Chang, et al.
Journal of Clinical Psychopharmacology|January 19, 2002
Shifting from haloperidol to risperidone for behavioral disturbances in dementia: safety, response predictors, and mood effectsHsien-Yuan Lane, Yue-Cune Chang, Muh-Hwan Su, et al.
Schizophrenia Research|January 27, 2004
Risperidone response and 5-HT6 receptor gene variance: genetic association analysis with adjustment for nongenetic confoundersHsien-Yuan Lane, Cheng-Chieh Lin, Chiung-Hsien Huang, et al.
Pageof 2

Showing results (1-10 of 20) with videos related to

Sort By:
Pageof 2
Journal of Clinical Psychopharmacology|August 13, 2002
Fluvoxamine-clozapine interaction: time-dependent?Mong-Liang Lu, Hsien-Yuan Lane, Wen-Ho Chang
Journal of Clinical Psychopharmacology|November 28, 2002
Dosing strategies of clozapine-fluvoxamine cotreatmentMong-Liang Lu, Hsien-Yuan Lane, Michael W Jann, et al.
Pharmacogenomics|May 11, 2005
Pharmacogenetic studies of response to risperidone and other newer atypical antipsychoticsHsien-Yuan Lane, Cheng-Chun Lee, Yi-Ching Liu, et al.
The Journal of Clinical Psychiatry|August 5, 2004
Adjunctive fluvoxamine inhibits clozapine-related weight gain and metabolic disturbancesMong-Liang Lu, Hsien-Yuan Lane, Shih-Ku Lin, et al.
Journal of Clinical Psychopharmacology|July 14, 2005
Regular-dose risperidone on QTc intervalsChih-Chiang Chiu, Wen-Ho Chang, Ming-Chyi Huang, et al.
Journal of Clinical Psychopharmacology|August 13, 2002
Influences of patient-related variables on risperidone efficacy for acutely exacerbated schizophrenia: analyses with rigorous statisticsHsien-Yuan Lane, Yue-Cune Chang, Chi-Chiang Chiu, et al.
The American Journal of Psychiatry|August 31, 2002
Association of risperidone treatment response with a polymorphism in the 5-HT(2A) receptor geneHsien-Yuan Lane, Yue-Cune Chang, Chih-Chiang Chiu, et al.
The International Journal of Neuropsychopharmacology|May 14, 2004
Effects of dopamine D2 receptor Ser311Cys polymorphism and clinical factors on risperidone efficacy for positive and negative symptoms and social functionHsien-Yuan Lane, Cheng-Chun Lee, Yue-Cune Chang, et al.
Journal of Clinical Psychopharmacology|January 19, 2002
Shifting from haloperidol to risperidone for behavioral disturbances in dementia: safety, response predictors, and mood effectsHsien-Yuan Lane, Yue-Cune Chang, Muh-Hwan Su, et al.
Schizophrenia Research|January 27, 2004
Risperidone response and 5-HT6 receptor gene variance: genetic association analysis with adjustment for nongenetic confoundersHsien-Yuan Lane, Cheng-Chieh Lin, Chiung-Hsien Huang, et al.
Pageof 2